NCT07216677 is a clinical trial of Chronic Disease Intervention CDI in Glaucoma, sponsored by Interstat LLC.

Who is sponsoring NCT07216677?

NCT07216677 is sponsored by Interstat LLC.

What drugs are being tested in NCT07216677?

Interventions in NCT07216677: Chronic Disease Intervention CDI.

What condition does NCT07216677 study?

NCT07216677 studies Glaucoma, AMD, Diabetic Retinopathy (DR).

Is NCT07216677 still recruiting?

NCT07216677 is currently active, enrolled. Last updated 15 October 2025.

Last reviewed 2025-10-15 · How we verify

NCT07216677

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases

Active, enrolled Last updated 15 October 2025

What this trial tests

trial testing Chronic Disease Intervention CDI in Glaucoma in 300 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

10 October 2024

Primary endpoint
25 October 2027

25 October 2027

Quick facts

Lead sponsor	Interstat LLC
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	300
Start date	10 October 2024
Primary completion	25 October 2027
Estimated completion	25 October 2027
Sites	1 location across United States

Drugs / interventions tested

Chronic Disease Intervention CDI

Conditions studied

Glaucoma — all drugs for Glaucoma →
AMD — all drugs for AMD →
Diabetic Retinopathy (DR) — all drugs for Diabetic Retinopathy (DR) →

Sponsor

Interstat LLC

Who can join

Adults 18 to 99, any sex, with Glaucoma or AMD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07216677 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Interstat LLC
Last refreshed: 15 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07216677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing